Abstract
The extracellular matrix (ECM) plays an important role in regulation of many aspects of tumor growth and response to therapies. However, the specifics of the interaction of chemotherapeutic agents with cancer cells in the presence of collagen, the major component of ECM, is still poorly investigated. In this study, we explored distribution of doxorubicin (DOX) and its effects on cancer cells’ metabolism in the presence of collagen with different structures in 3D models. For this, a combination of second harmonic generation imaging of collagen and multiphoton fluorescence microscopy of DOX, and metabolic cofactor NAD(P)H was used. It was found that collagen slowed down the diffusion of DOX and thus decreased the cellular drug uptake. Besides nuclei, DOX also targeted mitochondria leading to inhibition of oxidative phosphorylation, which was more pronounced in the cells growing in the absence of collagen. As a result, the cells in collagen displayed better viability upon treatment with DOX. Taken together, our data illustrate that tumor collagen contributes to heterogeneous and sub-optimal response to DOX and highlight the challenges in improving drug delivery and efficacy.
Funder
Ministry of Health of Russian Federation
Russian Science Foundation
Reference59 articles.
1. Drug penetration in solid tumours. Nature reviews;Minchinton;Cancer,2006
2. The extracellular matrix as a key regulator of intracellular signalling networks;Hastings;Br. J. Pharmacol.,2019
3. Concepts of extracellular matrix remodelling in tumour progression and metastasis;Winkler;Nat. Commun.,2020
4. The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity;Poltavets;Front. Oncol.,2018
5. Transport of drugs from blood vessels to tumour tissue. Nature reviews;Dewhirst;Cancer,2017